Skip to main content


Table 1 Correlation between the expression of miR-939 and therapy response in GC patients (N = 110)

From: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway

   miR-939 expression level  
All cases Low expression High expression P value
Therapy response
 CR + PR 57 15 42  
 NC + PD 53 41 12 P < 0.001
  1. CR complete response, PR partial response, NC no change, PD progressive disease